Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Wave Life Sci Ord Sh
(NQ:
WVE
)
5.850
+0.060 (+1.04%)
Streaming Delayed Price
Updated: 3:39 PM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Wave Life Sci Ord Sh
< Previous
1
2
Next >
Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days
March 29, 2023
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 22, 2023
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
March 02, 2023
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference
February 09, 2023
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Provides Positive Update on Proof-of-Concept Study for WVE-N531 in Duchenne Muscular Dystrophy
December 19, 2022
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets
December 13, 2022
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Present at the Stifel 2022 Healthcare Conference
November 09, 2022
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Webcast Conference Call of Third Quarter 2022 Financial Results on November 10, 2022
November 03, 2022
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Highlight Advancements from PRISM Platform at Upcoming Scientific Congresses
October 03, 2022
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Highlights Therapeutic Potential for WVE-006 for Alpha-1 Antitrypsin Deficiency and Progress Bringing RNA Editing to the Clinic During Analyst and Investor Event
September 28, 2022
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Webcast Conference Call of Second Quarter 2022 Financial Results on August 11, 2022
July 28, 2022
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.